Alpelisib

( DrugBank: Alpelisib / KEGG DRUG: Alpelisib )


4 diseases

138. Nerve cell migration disorder


Clinical trials : 2Drugs : 3 - (DrugBank : 2) / Drug target gene : 1 - Drug target pathways : 103 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

278. Huge lymphatic malformation with cervicofacial lesion


Clinical trials : 32Drugs : 32 - (DrugBank : 12) / Drug target genes : 8 - Drug target pathways : 136 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

279. Huge venous malformation with cervical, oral and pharyngeal diffuse lesion


Clinical trials : 24Drugs : 24 - (DrugBank : 12) / Drug target genes : 6 - Drug target pathways : 132 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

280. Huge arteriovenous malformation with cervicofacial or limb lesion


Clinical trials : 29Drugs : 31 - (DrugBank : 15) / Drug target genes : 12 - Drug target pathways : 163 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries